Company Filing History:
Years Active: 2021
Title: Michael Keefer: Innovator in Anti-Influenza Monoclonal Antibodies
Introduction
Michael Keefer is a prominent inventor based in Rochester, NY (US). He has made significant contributions to the field of immunology, particularly in the development of therapeutic solutions for influenza. His work focuses on creating broadly neutralizing antibodies that can combat various strains of the influenza virus.
Latest Patents
Michael Keefer holds a patent for a "Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof." This invention relates to monoclonal antibodies or antigen-binding fragments that can neutralize the influenza virus. The patent also covers therapeutic applications of these isolated antibodies, which have the potential to improve treatment options for influenza patients.
Career Highlights
Keefer is affiliated with the University of Rochester, where he conducts research and collaborates with other experts in the field. His innovative work has positioned him as a key figure in the development of new therapeutic strategies against influenza.
Collaborations
Some of his notable coworkers include James J Kobie and Michael Piepenbrink. Their collaborative efforts contribute to advancing research in the field of monoclonal antibodies and their applications.
Conclusion
Michael Keefer's contributions to the development of anti-influenza monoclonal antibodies highlight his role as an important inventor in the field of immunology. His work not only enhances our understanding of the influenza virus but also paves the way for new therapeutic interventions.